Characteristics of Clinical Trials Conducted in Japan Under the New GCP Guideline: Analysis of PMDA Audit Reports
Japanese Journal of Clinical Pharmacology and Therapeutics - Japan
doi 10.3999/jscpt.41.253
Full Text
Open PDFAbstract
Available in full text
Categories
Date
January 1, 2010
Authors
Publisher
Japanese Society of Clinical Pharmacology and Therapeutics